Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 2
2011 1
2012 1
2013 9
2014 9
2015 13
2016 16
2017 27
2018 30
2019 23
2020 28
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean jung hyun lee (371 results)?
Major clinical research advances in gynecologic cancer in 2019.
Kim M, Suh DH, Lee KH, Eom KY, Lee JY, Lee YY, Hansen HF, Mirza MR, Kim JW. Kim M, et al. Among authors: lee jy. J Gynecol Oncol. 2020 May;31(3):e48. doi: 10.3802/jgo.2020.31.e48. J Gynecol Oncol. 2020. PMID: 32319232 Free PMC article. Review.
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N. Cohen PA, et al. Among authors: lee jy. Gynecol Oncol. 2019 Aug;154(2):441-448. doi: 10.1016/j.ygyno.2019.04.679. Epub 2019 May 19. Gynecol Oncol. 2019. PMID: 31118141 Free article. Review.
4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma.
Kim HD, Park S, Jeong S, Lee YJ, Lee H, Kim CG, Kim KH, Hong SM, Lee JY, Kim S, Kim HK, Min BS, Chang JH, Ju YS, Shin EC, Song GW, Hwang S, Park SH. Kim HD, et al. Among authors: lee jy. Hepatology. 2020 Mar;71(3):955-971. doi: 10.1002/hep.30881. Epub 2019 Oct 18. Hepatology. 2020. PMID: 31353502 Free PMC article.
Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
Park JS, Lee ST, Nam EJ, Han JW, Lee JY, Kim J, Kim TI, Park HS. Park JS, et al. Among authors: lee jy. BMC Cancer. 2018 Jan 16;18(1):83. doi: 10.1186/s12885-017-3940-y. BMC Cancer. 2018. PMID: 29338689 Free PMC article.
Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2.
Eoh KJ, Kim JE, Park HS, Lee ST, Park JS, Han JW, Lee JY, Kim S, Kim SW, Kim JH, Kim YT, Nam EJ. Eoh KJ, et al. Among authors: lee jy. Cancer Res Treat. 2018 Jul;50(3):917-925. doi: 10.4143/crt.2017.220. Epub 2017 Sep 27. Cancer Res Treat. 2018. PMID: 29020732 Free PMC article.
Time for enhancing government-led primary prevention of cervical cancer.
Min KJ, Suh DH, Baba T, Chen X, Kim JW, Kobayashi Y, Kwon J, Lim MC, Lee JY, Nagase S, Park JY, Tangjitgamol S, Watari H. Min KJ, et al. Among authors: lee jy. J Gynecol Oncol. 2021 Jan;32(1):e12. doi: 10.3802/jgo.2021.32.e12. Epub 2020 Dec 11. J Gynecol Oncol. 2021. PMID: 33327045 Free PMC article. No abstract available.
An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION.
Lee JY, Yi JY, Kim HS, Lim J, Kim S, Nam BH, Kim HS, Kim JW, Choi CH, Kim BG; KGOG investigators. Lee JY, et al. Jpn J Clin Oncol. 2019 Aug 1;49(8):789-792. doi: 10.1093/jjco/hyz085. Jpn J Clin Oncol. 2019. PMID: 31671191 Clinical Trial.
Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.
Park JS, Nam EJ, Park HS, Han JW, Lee JY, Kim J, Kim TI, Lee ST. Park JS, et al. Among authors: lee jy. Cancer Res Treat. 2017 Oct;49(4):1012-1021. doi: 10.4143/crt.2016.433. Epub 2017 Jan 17. Cancer Res Treat. 2017. PMID: 28111427 Free PMC article.
Asian Society of Gynecologic Oncology International Workshop 2018.
Kong TW, Ryu HS, Kim SC, Enomoto T, Li J, Kim KH, Shim SH, Wang PH, Therasakvichya S, Kobayashi Y, Lee M, Shi T, Lee SW, Mikami M, Nagase S, Lim MC, Wang J, Wilailak S, Kim SW, Hong SH, Tan DS, Mandai M, Chang SJ, Huang RYJ, Ushijima K, Lee JY, Chen X, Ochiai K, Lee TS, Yang B, Kalam F, Lv Q, Ahmad MF, Yaznil MR, Modi KB, Manopunya M, Jeong DH, Lertkhachonsuk AA, Chung HH, Watari H, Jeon S. Kong TW, et al. Among authors: lee jy. J Gynecol Oncol. 2019 Mar;30(2):e39. doi: 10.3802/jgo.2019.30.e39. Epub 2019 Jan 14. J Gynecol Oncol. 2019. PMID: 30740961 Free PMC article.
How to use immune checkpoint inhibitor in ovarian cancer?
Park J, Lee JY, Kim S. Park J, et al. Among authors: lee jy. J Gynecol Oncol. 2019 Sep;30(5):e105. doi: 10.3802/jgo.2019.30.e105. J Gynecol Oncol. 2019. PMID: 31328467 Free PMC article. No abstract available.
141 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page